ES2045369T3 - Sistema terapeutico transdermico con norseudoefedrina como componente activo. - Google Patents

Sistema terapeutico transdermico con norseudoefedrina como componente activo.

Info

Publication number
ES2045369T3
ES2045369T3 ES89123091T ES89123091T ES2045369T3 ES 2045369 T3 ES2045369 T3 ES 2045369T3 ES 89123091 T ES89123091 T ES 89123091T ES 89123091 T ES89123091 T ES 89123091T ES 2045369 T3 ES2045369 T3 ES 2045369T3
Authority
ES
Spain
Prior art keywords
therapeutic system
norseudoefedrina
active component
weight
transdermic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89123091T
Other languages
English (en)
Inventor
Thomas Dr Hille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2045369T3 publication Critical patent/ES2045369T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Abstract

EL INVENTO SE REFIERE A UN SISTEMA TERAPEUTICO TRANSDERMAL PARA LA ADMINISTRACION CUTANEA DE UNA SUSTANCIA ACTIVA A PARTIR DE UNA CAPA POSTERIOR PERMEABLE AL PRINCIPIO ACTIVO, DE UNA CAPA DE RESERVA Y, EVENTUALMENTE, DE UNA CAPA PROTECTORA DESPRENDIBLE, CUYA CAPA DE RESERVA ES ADHESIVA Y QUE CONTIENE UN 10-90 % EN PESO DE MATERIAL POLIMERO, 0-30 % EN PESO DE PLASTIFICANTE, Y 0,1-20 % EN PESO DE UNA NOR-PSEUDOEFEDRINA.
ES89123091T 1988-12-22 1989-12-14 Sistema terapeutico transdermico con norseudoefedrina como componente activo. Expired - Lifetime ES2045369T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3843237A DE3843237A1 (de) 1988-12-22 1988-12-22 Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil

Publications (1)

Publication Number Publication Date
ES2045369T3 true ES2045369T3 (es) 1994-01-16

Family

ID=6369853

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89123091T Expired - Lifetime ES2045369T3 (es) 1988-12-22 1989-12-14 Sistema terapeutico transdermico con norseudoefedrina como componente activo.

Country Status (23)

Country Link
EP (1) EP0374725B1 (es)
JP (1) JP2602108B2 (es)
KR (1) KR950015055B1 (es)
AT (1) ATE93147T1 (es)
AU (1) AU614208B2 (es)
CA (1) CA2006425C (es)
CS (1) CS275356B2 (es)
DD (1) DD290581A5 (es)
DE (2) DE3843237A1 (es)
DK (1) DK651089A (es)
ES (1) ES2045369T3 (es)
FI (1) FI95772C (es)
HU (1) HU203280B (es)
IE (1) IE63878B1 (es)
IL (1) IL92678A (es)
MY (1) MY105074A (es)
NO (1) NO178784C (es)
NZ (1) NZ231909A (es)
PH (1) PH25854A (es)
PL (1) PL163292B1 (es)
PT (1) PT92650B (es)
YU (1) YU47075B (es)
ZA (1) ZA899879B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939376C1 (es) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
DE4342893C2 (de) * 1993-12-16 1999-09-23 Lohmann Gmbh & Co Kg Reversibel haftende, rückstandsfrei wieder ablösbare Haftklebemasse, Verfahren zu deren Herstellung und Verwendung als wiederverklebbare Haftklebeartikel
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
EP1239846A2 (en) * 1999-12-16 2002-09-18 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
KR100956865B1 (ko) * 2009-08-10 2010-05-11 주식회사 라이트론 슬라이드 가압패킹식 리니어 조명장치
EP3532037A4 (en) * 2016-10-31 2020-10-21 The Corporation Of Mercer University TRANSDERMAL ADMINISTRATION OF PHENETHYLAMINE MONOAMINE RELEASERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
ATE42901T1 (de) * 1984-03-05 1989-05-15 Nitto Denko Corp Haftendes arzneimittelpraeparat fuer perkutane absorption.
JPS60185713A (ja) * 1984-03-05 1985-09-21 Nitto Electric Ind Co Ltd 経皮吸収性製剤及びその製法
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
NO178784C (no) 1996-06-05
HUT53517A (en) 1990-11-28
JP2602108B2 (ja) 1997-04-23
AU614208B2 (en) 1991-08-22
CS8907193A3 (en) 1992-02-19
NO178784B (no) 1996-02-26
AU4684389A (en) 1990-06-28
HU203280B (en) 1991-07-29
IE63878B1 (en) 1995-06-14
EP0374725B1 (de) 1993-08-18
YU47075B (sh) 1994-12-28
FI896097A0 (fi) 1989-12-19
ZA899879B (en) 1990-09-26
IL92678A (en) 1994-06-24
FI95772C (fi) 1996-03-25
DK651089D0 (da) 1989-12-20
PT92650B (pt) 1995-09-12
FI95772B (fi) 1995-12-15
DK651089A (da) 1990-06-23
DE58905320D1 (de) 1993-09-23
IL92678A0 (en) 1990-09-17
ATE93147T1 (de) 1993-09-15
KR900009063A (ko) 1990-07-02
NZ231909A (en) 1991-06-25
MY105074A (en) 1994-07-30
EP0374725A3 (en) 1990-12-19
DD290581A5 (de) 1991-06-06
EP0374725A2 (de) 1990-06-27
YU240589A (en) 1991-04-30
NO895173L (no) 1990-06-25
CA2006425A1 (en) 1990-06-22
JPH03123728A (ja) 1991-05-27
PT92650A (pt) 1990-06-29
DE3843237A1 (de) 1990-07-05
KR950015055B1 (ko) 1995-12-21
NO895173D0 (no) 1989-12-21
DE3843237C2 (es) 1991-04-11
HU896721D0 (en) 1990-02-28
CA2006425C (en) 1995-09-05
PH25854A (en) 1991-12-02
IE894077L (en) 1990-06-22
PL163292B1 (pl) 1994-03-31
CS275356B2 (en) 1992-02-19

Similar Documents

Publication Publication Date Title
ES2086353T3 (es) Sistema terapeutico percutaneo que contiene como componente activo buprenorfina.
PT92652A (pt) Processo para a preparacao de um sistema terapeutico transdermico contendo fisostigmina como ingrediente activo
ES2057080T3 (es) Sistema terapeutico transdermal empleando fisostigmina como componente activo, asi como procedimiento para su preparacion.
ES2045369T3 (es) Sistema terapeutico transdermico con norseudoefedrina como componente activo.
DK1140039T3 (da) Transparente indretninger til perkutan nikotinadministration

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 374725

Country of ref document: ES